Michael Cooper Pearce

Michael Cooper Pearce discloses dealings in 2 companies, chiefly Pernix Therapeutics Holdings, Inc. and Journey Medical Corp. We count 49 filings; the first trade dates from 10 March 2010 and the latest from 25 June 2026.

Every open-market trade on record is a sale: 23 sales worth €1.1M. The rest of the record consists of 8 share grants and 18 option exercises.

Most recently, on 26 June 2026, the filings show a share grant in Journey Medical Corp. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.